NeuroCytonix Inc, is an emerging biotechnology company founded in January 2017 to develop and exploit disruptive medical technologies for regeneration of the nervous system. NeuroCytonix has developed a cutting-edge medical biotechnology business focused on tissue engineering and regeneration. This technology and its related protocols are dramatically improving the treatment of neurodegenerative diseases such as Alzheimer’s, Stroke, Parkinson’s, Autism, Cerebral Palsy and Schizophrenia.